THE EFFICACY AND SAFETY OF PROPHYLACTIC TENOFOVIR ALAFENAMIDE TO PREVENT HBsAg-POSITIVE CANCER PATIENTS UNDERGOING CHEMOTHERAPY FROM HBV REACTIVATION- AN INTERIM REPORT OF A PROSPECTIVE TRIAL
HEPATOLOGY(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要